We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+9.12%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$13.2B
AUM Growth
+$1.19B
Cap. Flow
+$398M
Cap. Flow %
3.01%
Top 10 Hldgs %
25.15%
Holding
2,888
New
90
Increased
233
Reduced
1,480
Closed
57

Top Sells

Rank Stock Value
1
EFA icon
iShares MSCI EAFE ETF
EFA
+$33.4M
2
AAPL icon
Apple
AAPL
+$20.4M
3
MSFT icon
Microsoft
MSFT
+$10.9M
4
TWTR
Twitter, Inc.
TWTR
+$9.15M
5
Y
Alleghany Corp
Y
+$7.32M

Sector Composition

Rank Sector Weight
1 Technology 19.63%
2 Healthcare 13.34%
3 Financials 12.1%
4 Consumer Discretionary 9.16%
5 Industrials 9.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DM
2251
DELISTED
Desktop Metal, Inc.
DM
$196K ﹤0.01%
14,446
ORC
2252
Orchid Island Capital
ORC
$1.32B
$196K ﹤0.01%
18,708
-1
-0% -$10
ASPN icon
2253
Aspen Aerogels
ASPN
$504M
$195K ﹤0.01%
16,572
SENS icon
2254
Senseonics Holdings Inc
SENS
$409M
$195K ﹤0.01%
9,472
-2,693
-22% -$62.2K
NSTG
2255
DELISTED
NanoString Technologies, Inc.
NSTG
$195K ﹤0.01%
24,478
CARE icon
2256
Carter Bankshares
CARE
$757M
$195K ﹤0.01%
11,740
-2,337
-17% -$40.9K
CRBU icon
2257
Caribou Biosciences
CRBU
$160M
$195K ﹤0.01%
31,003
BASE
2258
DELISTED
Couchbase
BASE
$194K ﹤0.01%
14,659
MCBS icon
2259
MetroCity Bankshares
MCBS
$1.05B
$194K ﹤0.01%
8,982
-2,861
-24% -$62.2K
CSV icon
2260
Carriage Services
CSV
$555M
$194K ﹤0.01%
7,052
TSVT
2261
DELISTED
2seventy bio
TSVT
$194K ﹤0.01%
20,718
NVTA
2262
DELISTED
Invitae Corporation
NVTA
$194K ﹤0.01%
104,324
-18,569
-15% -$45.3K
ROVR
2263
DELISTED
Rover Group, Inc. Class A Common Stock
ROVR
$194K ﹤0.01%
52,840
ACMR icon
2264
ACM Research
ACMR
$5.65B
$193K ﹤0.01%
25,060
CDRE icon
2265
Cadre Holdings
CDRE
$1.45B
$193K ﹤0.01%
9,570
PMVP icon
2266
PMV Pharmaceuticals
PMVP
$65.1M
$193K ﹤0.01%
22,144
TPB icon
2267
Turning Point Brands
TPB
$1.73B
$193K ﹤0.01%
8,903
LSXMK
2268
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
$192K ﹤0.01%
6,338
-74
-1% -$2.37K
AMNB
2269
DELISTED
American National Bankshares Inc
AMNB
$192K ﹤0.01%
5,199
-1,648
-24% -$60.1K
FORR icon
2270
Forrester Research
FORR
$224M
$192K ﹤0.01%
5,365
BWXT icon
2271
BWX Technologies
BWXT
$15.6B
$192K ﹤0.01%
3,303
-51
-2% -$2.93K
AMH icon
2272
American Homes 4 Rent
AMH
$12.3B
$192K ﹤0.01%
6,361
+123
+2% +$3.9K
MLNK
2273
DELISTED
MeridianLink
MLNK
$192K ﹤0.01%
13,959
JMSB icon
2274
John Marshall Bancorp
JMSB
$328M
$191K ﹤0.01%
6,643
SANA icon
2275
Sana Biotechnology
SANA
$1.1B
$191K ﹤0.01%
48,321

Similar funds

MetLife Investment Management's Q4 2022 Portfolio in Review

As of Q4 2022, MetLife Investment Management held 2,888 positions worth $13.2B, up 9.9% from $12B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

MetLife Investment Management deployed $398M of net new capital in Q4 2022, opening 90 new positions and adding to 233 existing holdings. Its largest new stake was Atlassian: 8,691 shares worth $1.12M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was iShares MSCI EAFE ETF, an estimated $33.4M trimmed.

  • MetLife Investment Management's largest Q4 2022 buy was Atlassian: 8,691 shares worth $1.12M.
  • MetLife Investment Management added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q4 2022, an estimated $651M increase.
  • MetLife Investment Management's biggest Q4 2022 reduction was iShares MSCI EAFE ETF, cutting an estimated $33.4M.
  • MetLife Investment Management fully exited Twitter, Inc. in Q4 2022, selling an estimated $9.15M.
  • MetLife Investment Management's ten largest holdings make up 25% of its $13.2B portfolio in Q4 2022.
  • MetLife Investment Management opened 90 new positions and closed 57 in Q4 2022.
  • MetLife Investment Management's portfolio value rose 9.9% quarter-over-quarter to $13.2B.

Based on MetLife Investment Management's 13F filing for Q4 2022, filed 15 Feb 2023.